Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
Clinical trial NCT03851432 · UNKNOWN
Trial details
- NCT number
- NCT03851432
- Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-30
- Primary completion
- 2020-04-30
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.